Aptevo Therapeutics APVO
NASDAQ APVO
$2.68 -0.08 (-2.81%)
As of: Aug 21, 2026 · 3:59 PM EDT

Aptevo Therapeutics (APVO) Change in Acquisitions & Divestments (2017 - 2018)

Aptevo Therapeutics (APVO) posted Change in Acquisitions & Divestments of $81.2 million for Q3 2018, up 53.57% sequentially from $52.8 million in Q2 2018, and up 237.73% YoY from $24.0 million in Q3 2017.

Aptevo Therapeutics (APVO) Change in Acquisitions & Divestments (2017 - 2018) Analysis & Trends

Aptevo Therapeutics has reported Change in Acquisitions & Divestments for 2 years, with the latest figure at $81.2 million in Q3 2018.

  • Quarterly Change in Acquisitions & Divestments rose 237.73% year-over-year to $81.2 million in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $177.4 million (changed N/A YoY) and the FY2018 annual result came in at $90.2 million, up 27.59% from the prior year.
  • Change in Acquisitions & Divestments rose to $81.2 million in Q3 2018 per APVO's latest filing, from $52.8 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $81.2 million in Q3 2018 and troughed at $8.1 million in Q1 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Aptevo Therapeutics 3.18 Mn -6.61 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2018 81.15 Mn
Sep 30, 2018 81.15 Mn
Jun 30, 2018 52.84 Mn
Jun 30, 2018 52.84 Mn
Mar 31, 2018 25.93 Mn
Mar 31, 2018 25.93 Mn
Dec 31, 2017 17.51 Mn
Dec 31, 2017 17.51 Mn
Sep 30, 2017 24.03 Mn
Sep 30, 2017 24.03 Mn
Jun 30, 2017 21.09 Mn
Jun 30, 2017 21.09 Mn
Mar 31, 2017 8.10 Mn
Mar 31, 2017 8.10 Mn